Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP556820.RA-1veUbNpR1UddnO49lvDIiJBCXIKA0gVvza5qDBhCVg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP556820.RA-1veUbNpR1UddnO49lvDIiJBCXIKA0gVvza5qDBhCVg130_assertion type Assertion NP556820.RA-1veUbNpR1UddnO49lvDIiJBCXIKA0gVvza5qDBhCVg130_head.
- NP556820.RA-1veUbNpR1UddnO49lvDIiJBCXIKA0gVvza5qDBhCVg130_assertion description "[Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556820.RA-1veUbNpR1UddnO49lvDIiJBCXIKA0gVvza5qDBhCVg130_provenance.
- NP556820.RA-1veUbNpR1UddnO49lvDIiJBCXIKA0gVvza5qDBhCVg130_assertion evidence source_evidence_literature NP556820.RA-1veUbNpR1UddnO49lvDIiJBCXIKA0gVvza5qDBhCVg130_provenance.
- NP556820.RA-1veUbNpR1UddnO49lvDIiJBCXIKA0gVvza5qDBhCVg130_assertion SIO_000772 23769451 NP556820.RA-1veUbNpR1UddnO49lvDIiJBCXIKA0gVvza5qDBhCVg130_provenance.
- NP556820.RA-1veUbNpR1UddnO49lvDIiJBCXIKA0gVvza5qDBhCVg130_assertion wasDerivedFrom befree-20150227 NP556820.RA-1veUbNpR1UddnO49lvDIiJBCXIKA0gVvza5qDBhCVg130_provenance.
- NP556820.RA-1veUbNpR1UddnO49lvDIiJBCXIKA0gVvza5qDBhCVg130_assertion wasGeneratedBy ECO_0000203 NP556820.RA-1veUbNpR1UddnO49lvDIiJBCXIKA0gVvza5qDBhCVg130_provenance.